Paszt A, Takács T, Rakonczay Z, Kaszaki J, Wolfard A, Tiszlavicz L, Lázár G, Duda E, Szentpáli K, Czakó L, Boros M, Balogh A, Lázár G
Department of Surgery, University of Szeged, Szeged, Hungary.
Pancreas. 2004 Jul;29(1):75-82. doi: 10.1097/00006676-200407000-00059.
The effects of glucocorticoids on acute pancreatitis (AP) have remained contradictory. The aim of this study was to investigate the time courses of the effects of the exogenous glucocorticoid agonists dexamethasone (DEX) and hydrocortisone (HYD) and a glucocorticoid antagonist (RU-38486) and to characterize the local and systemic responses in AP in rats. The glucocorticoid antagonist and agonists were administered just before AP induction. Serum amylase activity determinations, IL-6 bioassays, pancreatic weight/body weight ratio measurements, and survival analysis were performed. Liver and lung injuries were assessed via neutrophil leukocyte infiltration in myeloperoxidase (MPO) assays, tissue adenosine triphosphate (ATP) level determinations, and histology. In the glucocorticoid agonist groups, the survival rate increased, while the serum amylase level, the IL-6 activity, and the pancreatic weight/body weight ratio decreased significantly as compared with the control and RU-treated groups. AP resulted in significant decreases in tissue ATP levels in both the liver and the lung. In the DEX- or HYD-treated groups, the liver ATP levels were significantly elevated, while both the liver and the lung MPO levels were attenuated as compared with the AP and RU-treated groups. These results suggest that glucocorticoids may play important roles in mitigating the progression of the inflammatory reaction during the early phases of AP.
糖皮质激素对急性胰腺炎(AP)的影响一直存在争议。本研究的目的是探讨外源性糖皮质激素激动剂地塞米松(DEX)和氢化可的松(HYD)以及一种糖皮质激素拮抗剂(RU-38486)作用的时间进程,并描述大鼠AP中的局部和全身反应。在诱导AP之前给予糖皮质激素拮抗剂和激动剂。进行血清淀粉酶活性测定、IL-6生物测定、胰腺重量/体重比测量和生存分析。通过髓过氧化物酶(MPO)测定中的中性粒细胞浸润、组织三磷酸腺苷(ATP)水平测定和组织学评估肝和肺损伤。在糖皮质激素激动剂组中,与对照组和RU治疗组相比,生存率提高,而血清淀粉酶水平、IL-6活性和胰腺重量/体重比显著降低。AP导致肝脏和肺组织ATP水平显著降低。与AP组和RU治疗组相比,在DEX或HYD治疗组中,肝脏ATP水平显著升高,而肝脏和肺MPO水平均降低。这些结果表明,糖皮质激素可能在减轻AP早期炎症反应的进展中发挥重要作用。